DXR vs. APYX, XAIR, SEPA, CTSO, NSPR, SRTS, LUCD, CTCX, ICCM, and LNSR
Should you be buying Daxor stock or one of its competitors? The main competitors of Daxor include Apyx Medical (APYX), Beyond Air (XAIR), SEP Acquisition (SEPA), Cytosorbents (CTSO), InspireMD (NSPR), Sensus Healthcare (SRTS), Lucid Diagnostics (LUCD), Carmell (CTCX), IceCure Medical (ICCM), and LENSAR (LNSR). These companies are all part of the "surgical & medical instruments" industry.
Daxor (NASDAQ:DXR) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.
Apyx Medical has a consensus target price of $6.17, indicating a potential upside of 325.29%. Given Apyx Medical's higher probable upside, analysts clearly believe Apyx Medical is more favorable than Daxor.
Daxor has higher earnings, but lower revenue than Apyx Medical.
Daxor has a beta of -0.46, indicating that its stock price is 146% less volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 1.09, indicating that its stock price is 9% more volatile than the S&P 500.
Daxor has a net margin of 0.00% compared to Apyx Medical's net margin of -35.75%. Daxor's return on equity of 0.00% beat Apyx Medical's return on equity.
In the previous week, Apyx Medical had 4 more articles in the media than Daxor. MarketBeat recorded 5 mentions for Apyx Medical and 1 mentions for Daxor. Apyx Medical's average media sentiment score of 0.25 beat Daxor's score of -1.00 indicating that Apyx Medical is being referred to more favorably in the news media.
Apyx Medical received 77 more outperform votes than Daxor when rated by MarketBeat users.
1.3% of Daxor shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 60.6% of Daxor shares are owned by company insiders. Comparatively, 13.1% of Apyx Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Summary
Apyx Medical beats Daxor on 8 of the 12 factors compared between the two stocks.
Get Daxor News Delivered to You Automatically
Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DXR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
